220 related articles for article (PubMed ID: 15776864)
1. Frequencies of the breakpoint cluster region types of the BCR/ABL fusion gene in Mexican Mestizo patients with chronic myelogenous leukemia.
Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ruiz-Delgado GJ
Rev Invest Clin; 2004; 56(5):605-8. PubMed ID: 15776864
[TBL] [Abstract][Full Text] [Related]
2. Methylation of the major breakpoint cluster region (M-bcr) in Philadelphia-positive CML.
Mills KI; Sproul AM; Burnett AK
Leukemia; 1993 May; 7(5):707-11. PubMed ID: 7683349
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of breakpoint position within M-bcr in chronic myeloid leukemia.
Fioretos T; Nilsson PG; Aman P; Heim S; Kristoffersson U; Malm C; Simonsson B; Turesson I; Mitelman F
Leukemia; 1993 Aug; 7(8):1225-31. PubMed ID: 8350622
[TBL] [Abstract][Full Text] [Related]
4. Interpretation of submicroscopic deletions of the BCR or ABL gene should not depend on extra signal-FISH: problems in interpretation of submicroscopic deletion of the BCR or ABL gene with extra signal-FISH.
Kim YR; Cho HI; Yoon SS; Park S; Kim BK; Lee YK; Chun H; Kim HC; Lee DS
Genes Chromosomes Cancer; 2005 May; 43(1):37-44. PubMed ID: 15723338
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the clinical relevance of the breakpoint location within M-BCR and the type of chimeric mRNA in chronic myelogenous leukemia.
Rozman C; Urbano-Ispizua A; Cervantes F; Rozman M; Colomer D; Féliz P; Pujades A; Vives Corrons JL
Leukemia; 1995 Jun; 9(6):1104-7. PubMed ID: 7596178
[TBL] [Abstract][Full Text] [Related]
6. Chronic myelocytic leukemia--Part I: History, clinical presentation, and molecular biology.
Randolph TR
Clin Lab Sci; 2005; 18(1):38-48. PubMed ID: 15747785
[TBL] [Abstract][Full Text] [Related]
7. Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11).
Mundhada S; Luthra R; Cano P
BMC Cancer; 2004 Jun; 4():25. PubMed ID: 15202948
[TBL] [Abstract][Full Text] [Related]
8. Relationship of the BCR gene breakpoint and the type of BCR/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia.
Prejzner W
Med Sci Monit; 2002 May; 8(5):BR193-7. PubMed ID: 12011769
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of the BCR/ABL1 transcripts in Mexican patients with chronic myelogenous leukemia.
Meza-Espinoza JP; Gutiérrez-Angulo M; Vázquez-Cárdenas A; Delgado-Lamas JL; Esparza-Flores MA; González-García JR
Rev Invest Clin; 2007; 59(5):338-41. PubMed ID: 18268888
[TBL] [Abstract][Full Text] [Related]
10. BCR and its mutants, the reciprocal t(9;22)-associated ABL/BCR fusion proteins, differentially regulate the cytoskeleton and cell motility.
Zheng X; Güller S; Beissert T; Puccetti E; Ruthardt M
BMC Cancer; 2006 Nov; 6():262. PubMed ID: 17090304
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of BCR-ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR.
Goh HG; Hwang JY; Kim SH; Lee YH; Kim YL; Kim DW
Transl Res; 2006 Nov; 148(5):249-56. PubMed ID: 17145570
[TBL] [Abstract][Full Text] [Related]
12. P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells.
Campbell ML; Li W; Arlinghaus RB
Oncogene; 1990 May; 5(5):773-6. PubMed ID: 2140598
[TBL] [Abstract][Full Text] [Related]
13. New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia.
Saglio G; Guerrasio A; Rosso C; Zaccaria A; Tassinari A; Serra A; Rege-Cambrin G; Mazza U; Gavosto F
Blood; 1990 Nov; 76(9):1819-24. PubMed ID: 2224129
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of Philadelphia-positive childhood chronic myeloid leukemia.
Fioretos T; Heim S; Garwicz S; Ludvigsson J; Mitelman F
Leukemia; 1992 Jul; 6(7):723-5. PubMed ID: 1625493
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of chronic myelogenous leukemia cells harboring a BCR-ABL B3A2 junction by antisense oligonucleotides targeted at the B2A2 junction.
Mahon FX; Ripoche J; Pigeonnier V; Jazwiec B; Pigneux A; Moreau JF; Reiffers J
Exp Hematol; 1995 Dec; 23(14):1606-11. PubMed ID: 8542954
[TBL] [Abstract][Full Text] [Related]
16. Bcr: a negative regulator of the Bcr-Abl oncoprotein in leukemia.
Arlinghaus RB
Oncogene; 2002 Dec; 21(56):8560-7. PubMed ID: 12476302
[TBL] [Abstract][Full Text] [Related]
17. [Detection on BCR-ABL fusion gene in Ph1 chromosome positive leukemia by "nested" retrotranscriptase/polymerase chain reaction].
Huang W; Cao Q; Lu Y
Zhonghua Yi Xue Za Zhi; 1994 Nov; 74(11):662-5, 708. PubMed ID: 7866899
[TBL] [Abstract][Full Text] [Related]
18. BCR gene recombines with genomically distinct sites on band 11Q13 in complex BCR-ABL translocations of chronic myeloid leukemia.
Morris C; Jeffs A; Smith T; McDonald M; Board P; Kennedy M; Fitzgerald P
Oncogene; 1996 Feb; 12(3):677-85. PubMed ID: 8637725
[TBL] [Abstract][Full Text] [Related]
19. [c-abl gene and bcr-abl fused gene in Ph1-positive leukemias].
Okabe M; Kunieda Y; Miyazaki T; Kakinuma M
Nihon Rinsho; 1990 Aug; 48(8):89-97. PubMed ID: 2255098
[No Abstract] [Full Text] [Related]
20. [Chronic myelogenous leukemia expressing two bcr-abl chimeric mRNA; a case report].
Hashimoto S; Hiyoshi M; Hino M; Yamane T; Ota T; Koh KR; Tagawa S; Tatsumi N
Rinsho Ketsueki; 1997 Jan; 38(1):72-4. PubMed ID: 9028165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
